Global Generic Drug Market 2025 – 2034

The Custom Market Insights (CMI) says that the Global Generic Drug Market Size was worth USD 491.35 Billion in 2024 and will be worth USD 519.11 Billion in 2025. By the end of 2034, it is expected to be worth USD 926.54 Billion at a CAGR of about 6.55% from 2025 to 2034.

Recently, there has been more demand for generic drugs because people are becoming more aware of the many low-cost options available from both the public and private sectors. Also, the main players in the market have done a lot of research and development to bring cutting-edge drugs into the generic drug market. This has helped the market grow at an amazing rate over the course of the projection period.

The huge number of older people has led to a huge increase in the number of patients around the world, which has helped the market reach new heights. People often choose generic drugs because they work the same way on the body as brand-name drugs do. The generic medication market has also grown a lot because so many people around the world have chronic diseases. The market always needs certain medicines because it takes a long time to fully treat chronic illnesses. Because of this, the effectiveness of these generic drugs has been improving, which has sped up the growth of the market.

Analysis of COVID-19:

The COVID pandemic outbreak had a big effect on the generic medication industry because there was so much demand and supply in the market.

The people who got sick from the epidemic also had to deal with a number of other illnesses and conditions, which made things even harder for everyone financially. Because of this, it became clear that the leading market players' offer of cutting-edge generic drugs was a possible solution for these people.

People are buying more and more generic drugs because they are similar to the main ingredients in the medicine. This has allowed the market to grow a lot during the forecast period. Because of this, there was a huge demand in the market for the sales and supply of drugs that affect the heart and blood vessels. The pandemic also saw a huge rise in the market for generic drugs because so many people got sick. Patients chose branded and pure generic medications to lower the overall cost of therapy.

Things that are growing:

The biggest companies in the generic drug market have come out with new drugs that use the latest technology to treat patients and speed up recovery while having fewer bad effects on the body. T

The major players in the market have made big investments to improve and develop the production and manufacturing process for generic drugs. This has helped the market's economy.

Insights by Segment

Brand-based segmentation of the market for generic drugs

The segment of pure generics based on the brand has grown the fastest because there is a lot of demand for them. The pure genetics market has also grown a lot, and this trend is likely to continue in the future as more people learn about the originality and quality of drugs.

Pure generic drugs are taking over the market right now because the big companies are competing with each other to come up with new, very high-quality drugs. Pure generic drugs are much more effective than their competitors when it comes to treating illnesses. People's health has improved a lot since they started using pure generic drugs, which has led to longer lives.

Scope of the Report

Details about the Report's Feature

The market will be worth $519.11 billion in 2025.

Estimated Market Size in 2034: USD 926.54 Billion

CAGR Growth Rate: 6.55% CAGR

Year of the Base: 2024

The time period for the forecast is 2025 to 2034.

Key Segment: By brand (branded generic drugs, pure generic drugs), by route of administration (topical, oral, parental, and others), by therapeutic application (cardiovascular system, oncology, dermatology, respiratory system, central nervous system, and others), by distribution channel (retail pharmacies, hospital pharmacies, and others), and by region

Report Coverage: Company Profile, Revenue Estimation and Forecast, Competitive Landscape, Growth Factors, and Recent Trends

Geographic Scope: North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America

Options for Buying: Ask for personalized buying options that meet your research needs. Show more